Overexpression of HER2/neu Oncoprotein in Cytologic Specimens

Acta Cytologica

Volumn 48, Issue 2, 2004, Pages 199-206

  Mitteldorf, Cristina A T S ^a,c   Leite, Kátia R M ^a   Inês Meirelles, Maria ^a   Gattas, Gilka J F ^b   Camara Lopes, L H ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Aspiration biopsy; HER2 proto oncogene protein; Immunocytochemistry; Immunohistochemistry

Indexed keywords

ADENOCARCINOMA; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER; CENTRIFUGATION; COLORECTAL CARCINOMA; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HEPATOBILIARY SYSTEM CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; MALE; ONCOGENE NEU; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 1642378594     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326316     Document Type: Article

References (36)

1. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-1139
2. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T: The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986;232:1644-1646
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712
4. Berger MS, Locher GW, Saurer S, Gullik WJ, Waterfield MD, Groner B, Hynes NE: Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 1998;48:1238-1243
5. Koeppen HKW, Wright BD, Burt AD, Quirke P, McNicol AM, Dybdal NO, Sliwkowski MX, Hillan KJ: Overexpression of Her2/neu in solid tumours: An immunohistochemical survey. Histopathology 2001;38:96-104
6. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996;13:63-72
7. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ: Her2/neu gene amplification characterized by fluorescent in-situ hybridization: Poor prognosis in node-negative breast carcinomas. J Clin Oncol 1997;15:2894-2904
8. Ross JS, Flecther JA: HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol (suppl) 1999;112:S53-S67
9. Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL, Wolmark N: erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst 1998;90:1361-1370
10. Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, Norton L, Liu ET: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst 1998;90:1346-1360
11. Ascoli V, Scalzo CC, Nardi F: c-erbB-2 oncoprotein immunostaining in serous effusions. Cytopathology 1993;4:207-218
12. Jorda M, Ganjei P, Nadji M: Retrospective c-erbB-2 immunostaining in aspiration cytology of breast cancer. Diagn Cytopathol 1994;11:262-265
13. Corkill ME, Katz R: Immunocytochemical staining of c-erbB-2 oncogene on fine-needle aspirates of breast carcinoma: A comparison with tissue sections and other breast cancer prognostic factors. Diagn Cytopathol 1994;11:250-254
14. Martin AW, Davey DD: Comparison of immunoreactivity of neu oncoprotein in fine-needle aspirates and paraffin-embedded material. Diagn Cytopathol 1995;12:42-45
15. Tiniakos DG, Robinson KB, Greenwood H, Cullen P, Cook AM, Horne CHW, Angus B: c-erbB-2 and p53 expression in breast cancer fine needles aspirates. Cytopathology 1996;7:178-186
16. Troncone G, Panico L, Vetrani A, de Divitiis B, Zeppa P, Fulciniti F, Pettinato G, Palombini L: c-erB-2 expression in FNAB smears and matched surgical specimens of breast cancer. Diagn Cytopathol 1996;14:135-139
17. Suthipintawong C, Leong AS-Y, Chan K-W, Vinyuvat S: Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: A simplified method with formalin fixation. Diagn Cytopathol 1997;17:127-133
18. Sinha SK, Singh UR, Bhatia A: c-erbB-2 oncoprotein expression: Correlation with the Ki-67 labeling index and AgNOR counts in breast carcinoma on fine needle aspiration cytology. Acta Cytol 1996;40:1217-1220
19. Sinha SK, Singh UR, Bhatia A, Gupta S: Cytomorphological features, AgNOR counts and c-erbB-2 in carcinoma breast. J Indian Med Assoc 1998;96:71-76
20. Solomides CC, Zimmerman R, Bibbo M: Semiquantitative assessment of c-erbB-2 (HER-2) status in cytology specimens and tissue sections from breast carcinoma. Analyt Quant Cytol Histol 1999;21:121-125
21. Mezzelani A, Alasio L, Bartoli C, Bonora MG, Pierotti MA, Rilke F, Pilotti S: c-erbB2/neu gene and chomosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. Br J Cancer 1999;80:519-525
22. MacKee GT, Tambouret RH, Finkelstein D: A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material. Appl Immunohistochem Mol Morphol 2001;9:352-357
23. Dey P, Luthra UK, George SS, Prasad A: c-erbB-2 expression and DNA ploidy in breast cancer on fine-needle aspiration cytology material. Diagn Cytopathol 2000;22:261-262
24. Mitteldorf CATS, Alves VAF, Kanamura CT, Carneiro PC: Immunocytochemistry applied to aspiration biopsy cytology: Diagnostic contribution in 100 cases of previously stained, routine cases. Acta Cytol 1999;43:218-226
25. Masood S, Bui MM: Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: An immunohistochemical study. Ann Clin Lab Sci 2000;30:259-265
26. Simon R, Nocito A, Hübscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Moch H, Wilber K, Schötzau A, Kononen J, Sauter G: Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001;93:1141-1146
27. Penault-Llorca F, Adelaide J, Houvenaeghel G, Hassoun J, Birnbaum D, Jacquemier J: Optimization of immunohistochemical detection of erbB-2 in human breast cancer: Impact of fixation. J Pathol 1994;173:65-75
28. Press MF, Hung G, Godolphin W, Slamon DJ: Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 1994;54:2771-2777
29. Mitchell MS, Press MF: The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer. Semin Oncol 1999;26:108-116
30. Thomson TA, Hayes MM, Spinelli JJ, Hilland E, Sawrenko C, Phillips D, Dupuis B, Parker RL: HER-2/neu in breast cancer: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol 2001;14:1079-1086
31. Zarbo RJ, Sledge Jr GW: HER2 and the future of predictive markers in targeted cancer therapies. Proc of 91st Annual Meeting of the United States and Canadian Academy of Pathology, Chicago, February 23-March 1, 2002
32. Szöllösi J, Balázs M, Feuerstein BG, Benz CC, Waldman FM: ERBB-2 (HER2/neu) gene copy number, p185 her-2 overexpression, and intratumor heterogeneity in human breast cancer. Cancer Res 1995;55:5400-5407
33. Persons DL, Borelli KA, Hsu PH: Quantitation of HER2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod Pathol 1997;10:720-727
34. Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN: HER2 testing in patients with breast cancer: Poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc 2002;77:148-154
35. Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA: HER2/neu expression in malignant lung tumors. Semin Oncol (suppl) 2002;29:51-58
36. Klijanienko J, Couturier J, Galut M, El-Nagar AK, Maciorowski Z, Padoy E, Mosseri V, Vielh P: Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER2/neu gene amplification in breast cancer fine-needle samples. Cancer Cytopathol 1999;87:312-318